Geftinat 250 mg is an oral medication containing Gefitinib, a targeted therapy used for treating non-small cell lung cancer (NSCLC). It belongs to the class of tyrosine kinase inhibitors (TKIs) and works by blocking the epidermal growth factor receptor (EGFR), which plays a crucial role in the growth and spread of cancer cells. By inhibiting this protein, Geftinat 250 mg helps slow or stop the progression of lung cancer, improving patient outcomes. Manufactured by Natco Pharma, this medicine provides an effective, non-invasive treatment option in a convenient strip packaging for easy use.
Benefits of Geftinat 250 mg Strip:
- Targeted Cancer Therapy: Specifically designed to inhibit EGFR, reducing cancer cell growth.
- Convenient Oral Treatment: Available in easy-to-carry strip packaging for patient convenience.
- Effective for NSCLC: Recommended for patients with EGFR mutation-positive non-small cell lung cancer.
- Trusted Manufacturer: Produced by Natco Pharma, a reputable name in oncology medications.
- Improves Quality of Life: Helps manage lung cancer symptoms and slows disease progression.
Specification/Additional Details:
- Strength: 250 mg
- Packaging Type: Strip Pack
- Packaging Size: 10 tablets per strip
- Brand: Geftinat
- Manufactured By: Natco Pharma
- Country of Origin: India
For bulk orders, wholesale pricing, and further inquiries, feel free to contact us!
Reviews
There are no reviews yet.